ARK combined analytical dataset
Malawi, 2018 - 2019
Get Microdata
Reference ID
DDI-MWI-MEIRU-ARK-2018-v01
Producer(s)
Professor Amelia (Mia) Crampin
Collections
Metadata
Created on
Nov 14, 2025
Last modified
Nov 18, 2025
Page views
18045
Downloads
172
- Data files
- ark_combined_final_meiruid
- ark_iohex_results
malaria sample fasting status (D) (mal_basefoll)
Data file: ark_combined_final_meiruid
Overview
Valid:
1000
Invalid:
321
Type:
Discrete
Decimal:
0
Start:
1070
End:
1072
Width:
3
Range:
1 - 999
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Visit 1 | 0 |
0%
|
| 2 | TSD/GSC-2 month follow up | 0 |
0%
|
| 3 | ART-2 month follow up | 0 |
0%
|
| 4 | Visit 4 | 0 |
0%
|
| 6 | 6 month follow up | 0 |
0%
|
| 8 | 8 week follow up | 0 |
0%
|
| 9 | 9 month follow up | 0 |
0%
|
| 10 | 10 week follow up | 0 |
0%
|
| 12 | 12 month follow up | 0 |
0%
|
| 14 | 14 week follow up | 0 |
0%
|
| 15 | 15 month follow up | 0 |
0%
|
| 16 | 16 week follow up | 0 |
0%
|
| 18 | 18 month follow up | 0 |
0%
|
| 21 | 21 month follow up | 0 |
0%
|
| 24 | 24 month follow up | 0 |
0%
|
| 26 | 26 week follow up | 0 |
0%
|
| 27 | 27 month follow up | 0 |
0%
|
| 30 | 30 month follow up | 0 |
0%
|
| 33 | 33 month follow up | 0 |
0%
|
| 36 | 36 month follow up | 0 |
0%
|
| 39 | 39 month follow up | 0 |
0%
|
| 42 | 42 month follow up | 0 |
0%
|
| 52 | ??? | 0 |
0%
|
| 100 | Week O6 - Control | 0 |
0%
|
| 101 | Week 26 - Control | 0 |
0%
|
| 102 | Acute episode | 0 |
0%
|
| 103 | AHS-Stage 1 | 0 |
0%
|
| 104 | ARV-Stage 1 | 0 |
0%
|
| 105 | Baby 1 | 0 |
0%
|
| 106 | Baseline fasting | 244 |
24.4%
|
| 107 | Baseline | 0 |
0%
|
| 108 | Baseline random | 756 |
75.6%
|
| 109 | Child's sample | 0 |
0%
|
| 110 | Cord blood | 0 |
0%
|
| 111 | excluded - LIS hiv positives | 0 |
0%
|
| 113 | Follow up | 0 |
0%
|
| 114 | Glucose tolerance | 0 |
0%
|
| 115 | iohex 1 | 0 |
0%
|
| 116 | iohex 2 | 0 |
0%
|
| 117 | iohex 3 | 0 |
0%
|
| 118 | iohex 4 | 0 |
0%
|
| 119 | IIB follow up 1 | 0 |
0%
|
| 120 | Initial screening | 0 |
0%
|
| 121 | LIS clinical review | 0 |
0%
|
| 122 | Mother's sample | 0 |
0%
|
| 123 | Old - toxoplasmosis test required | 0 |
0%
|
| 124 | Old | 0 |
0%
|
| 125 | Pre baseline | 0 |
0%
|
| 126 | Gates Controls suspected to be progressor | 0 |
0%
|
| 127 | PVC follow up week 1 | 0 |
0%
|
| 128 | PVC 12 week follow up | 0 |
0%
|
| 129 | PVC 18 week follow up | 0 |
0%
|
| 130 | PVC 4 week follow up | 0 |
0%
|
| 131 | PVC 6 week follow up | 0 |
0%
|
| 132 | Randomisation screening | 0 |
0%
|
| 133 | Stimulated with BCG | 0 |
0%
|
| 134 | Unstimulated | 0 |
0%
|
| 135 | Young - sickle cell test and toxoplasmosis test required | 0 |
0%
|
| 136 | Young - sickle cell test | 0 |
0%
|
| 137 | NTN pilot1 | 0 |
0%
|
| 998 | Unknown | 0 |
0%
|
| 999 | Missing | 0 | |
| Sysmiss | 321 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Definition
malaria sample fasting status
Imputation and derivation
Derivation
variable: basefoll (table[s]: ser_specimen, lab_specimen)